Drugs / Huatuo Zaizao Pills
Huatuo Zaizao Pills
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04910256 | May 2021 → Jun 2023 | ischemic stroke | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Completed | Met primary |
| Phase 4 | NCT01758536 | Dec 2012 → Dec 2014 | ischemic stroke | Huashan Hospital | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Huatuo Zaizao Pills | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04910256 ↗ |
| Known as | HTZZ | “OBJECTIVE: To evaluate the effects of Chinese patent medicine Huatuo Zaizao Pill (HTZZ) on neurological function and limb motor in ischemic stroke (IS) patients during convalescence.” PMID 40232598 ↗ Apr 2025 |
| Known as | Huatuo Zaizao Pill | “OBJECTIVE: To evaluate the effects of Chinese patent medicine Huatuo Zaizao Pill (HTZZ) on neurological function and limb motor in ischemic stroke (IS) patients during convalescence.” PMID 40232598 ↗ Apr 2025 |
| Modality | Traditional medicine (herbal / TCM) | “Chinese patent medicine Huatuo Zaizao Pill” PMID 40232598 ↗ Apr 2025 |
| Route | Oral | “The HTZZ group was treated with oral HTZZ (8 g, thrice daily)” PMID 40232598 ↗ Apr 2025 |